BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 26639704)

  • 1. Essential medicines for children in Armenia.
    Kazaryan I; Vardanyan L
    Int J Risk Saf Med; 2015; 27 Suppl 1():S43-4. PubMed ID: 26639704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Armenia: implementation of national program of malaria control].
    Grigorian G; Solkhomonian L
    Med Parazitol (Mosk); 2001; (1):21-4. PubMed ID: 11548307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential medicines lists for children of WHO, India, South Africa, and EML of China: A comparative study.
    Liu D; Cheng J; Zhang LL; Li YP; Zeng LN; Zhang C; Gui G
    J Evid Based Med; 2017 Nov; 10(4):271-280. PubMed ID: 28276634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights from the WHO and National Lists of Essential Medicines: Focus on Pediatric Diabetes Care in Africa.
    Rowlands A; Ameyaw E; Rutagarama F; Dipesalema J; Majaliwa ES; Mbogo J; Ogle GD; Chanoine JP
    Horm Res Paediatr; 2018; 90(2):82-92. PubMed ID: 30048982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Availability of Essential Medicines for Pediatric Oncology in Armenia.
    Simonyan T; Papyan R; Danielyan S; Sargsyan L; Grigoryan V; Topchyan H; Azaryan A; Tananyan A; Muradyan A; Tamamyan G
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):991-994. PubMed ID: 31030465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative evaluation of essential medicines lists: the South African case study.
    Perumal-Pillay VA; Suleman F
    BMC Health Serv Res; 2016 Dec; 16(1):687. PubMed ID: 27955710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Availability of Pediatric Formulations in Public Health Care System in India: A Case Study.
    Roy V; Singhal S; Tayal H; Dubey AP
    Indian J Pediatr; 2021 Mar; 88(3):227-234. PubMed ID: 32086758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicines for cancers in children: The WHO model for selection of essential medicines.
    Robertson J; Magrini N; Barr R; Forte G; Ondari C
    Pediatr Blood Cancer; 2015 Oct; 62(10):1689-93. PubMed ID: 25929524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are age-appropriate antibiotic formulations missing from the WHO list of essential medicines for children? A comparison study.
    Ivanovska V; Leufkens HG; Rademaker CM; Zisovska E; Pijnenburg MW; van Dijk L; Mantel-Teeuwisse AK
    Arch Dis Child; 2017 Apr; 102(4):352-356. PubMed ID: 28119403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 25 years of the WHO essential medicines lists: progress and challenges.
    Laing R; Waning B; Gray A; Ford N; 't Hoen E
    Lancet; 2003 May; 361(9370):1723-9. PubMed ID: 12767751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential medicines for reproductive health: developing evidence based interagency list.
    Logez S; Jayasekar S; Moller H; Ahmed K; Patel MU
    South Med Rev; 2011 Dec; 4(2):62-8. PubMed ID: 23093884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approval status and evidence for WHO essential medicines for children in the United States, United Kingdom, and Japan: a cross-sectional study.
    Shimazawa R; Ikeda M
    J Pharm Policy Pract; 2017; 10():4. PubMed ID: 28070339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WHO and national lists of essential medicines in Mexico, Central and South America, and the Caribbean: are they adequate to promote paediatric endocrinology and diabetes care?
    Rowlands A; Acosta-Gualandri A; Guevara-Aguirre J; Chanoine JP
    BMJ Glob Health; 2016; 1(3):e000114. PubMed ID: 28588968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indian Essential Medicine List for Children: Time to Revisit.
    Singhal S; Dutta S; Thakker Z; Shah R
    Cureus; 2023 Feb; 15(2):e35340. PubMed ID: 36974248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decision criteria for selecting essential medicines and their connection to guidelines: an interpretive descriptive qualitative interview study.
    Piggott T; Moja L; Akl EA; Lavis JN; Cooke G; Kredo T; Hogerzeil HV; Huttner B; Alonso-Coello P; Schünemann H
    J Clin Epidemiol; 2023 Feb; 154():146-155. PubMed ID: 36584732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the Appropriateness of Formulations on the WHO Model List of Essential Medicines for Children: Development of a Paediatric Quality Target Product Profile Tool.
    Walsh J; Masini T; Huttner BD; Moja L; Penazzato M; Cappello B
    Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential medicines for emergency care in Africa.
    Broccoli MC; Pigoga JL; Nyirenda M; Wallis L; Calvello Hynes EJ
    Emerg Med J; 2018 Jul; 35(7):412-419. PubMed ID: 29627770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of the Essential Medicines List, Standard Treatment Guidelines and prescribing restrictions, as an integrated strategy to enhance quality, efficacy and safety of and improve access to essential medicines in Papua New Guinea.
    Joshua IB; Passmore PR; Sunderland BV
    Health Policy Plan; 2016 May; 31(4):538-46. PubMed ID: 26378052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WHO essential medicines for children 2011-2019: age-appropriateness of enteral formulations.
    Orubu ESF; Duncan J; Tuleu C; Turner MA; Nunn A
    Arch Dis Child; 2022 Apr; 107(4):317-322. PubMed ID: 34479858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based clinical guidelines in Kyrgyz Republic.
    Zurdinova AA
    Int J Risk Saf Med; 2015; 27 Suppl 1():S45-6. PubMed ID: 26639705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.